India to Australia: Metoclopramide Export Trade Route

The India to Australia Metoclopramide corridor is one of India's established pharmaceutical export routes, with 58 shipments documented worth a combined $3.0M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's metoclopramide manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $51.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with metoclopramide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 23.7%, placing it at rank #2 among India's top metoclopramide export destinations globally.

On the import side, key buyers of Indian metoclopramide in Australia include NA, BAXTER HEALTHCARE PTY. LIMITED, TO THE ORDER and 15 others. NA is the single largest importer with 14 shipments valued at $1.8M USD.

India's metoclopramide exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, IPCA LABORATORIES LIMITED — together account for 98% of total trade value on this route. The average shipment value of $51.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as metoclopramide hcl 5mg/ml solution for injection 2ml glass ampoule and harmless medicines:apo-metoclopramide 10, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 14 shipments worth $1.8M USD — representing 61% of all metoclopramide imports from India on this route. A total of 18 buyers are active on this corridor.